Buckingham Capital Management, Inc. Gilead Sciences, Inc. Transaction History

Buckingham Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $1.35 Million - $1.65 Million	-18,594 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $41,622 - $48,859	-585 Reduced 3.05%	18,594 $1.33 Million
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $7,571 - $8,974	-105 Reduced 0.54%	19,179 $1.55 Million
Q2 2017 Aug 10, 2017	BUY	N/A	19,284	19,284 $1.37 Million

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Buckingham Capital Management, Inc. with notifications on news.